These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8879962)

  • 1. The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes.
    Signore A; Fiore V; Chianelli M; Procaccini E; Barone R; Ronga G; Negri M; Pozzilli P
    Diabetes Res Clin Pract; 1996 Jul; 33(2):83-7. PubMed ID: 8879962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.
    Fontbonne A; Charles MA; Juhan-Vague I; Bard JM; André P; Isnard F; Cohen JM; Grandmottet P; Vague P; Safar ME; Eschwège E
    Diabetes Care; 1996 Sep; 19(9):920-6. PubMed ID: 8875083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.
    Fanghänel G; Sánchez-Reyes L; Trujillo C; Sotres D; Espinosa-Campos J
    Diabetes Care; 1996 Nov; 19(11):1185-9. PubMed ID: 8908377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
    Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approach in insulin resistance with acanthosis nigricans.
    Tankova T; Koev D; Dakovska L; Kirilov G
    Int J Clin Pract; 2002 Oct; 56(8):578-81. PubMed ID: 12425366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM.
    Jansson PA; Gudbjörnsdóttir HS; Andersson OK; Lönnroth PN
    Diabetes Care; 1996 Feb; 19(2):160-4. PubMed ID: 8718438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients.
    Raptis AE; Tountas NB; Yalouris AG; Halvatsiotis PG; Raptis SA
    Horm Metab Res; 1996 Feb; 28(2):89-94. PubMed ID: 8867905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved endothelial function with metformin in type 2 diabetes mellitus.
    Mather KJ; Verma S; Anderson TJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
    D'Argenzio R; Cavallo P; Merante D; Morelli A
    Minerva Endocrinol; 1996 Sep; 21(3):101-10. PubMed ID: 9072666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.
    Sambol NC; Chiang J; O'Conner M; Liu CY; Lin ET; Goodman AM; Benet LZ; Karam JH
    J Clin Pharmacol; 1996 Nov; 36(11):1012-21. PubMed ID: 8973990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.
    McNulty SJ; Ur E; Williams G;
    Diabetes Care; 2003 Jan; 26(1):125-31. PubMed ID: 12502668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.